Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editingBenjamin P. Kleinstiver, J. Keith Joung, Jonathan Y. Hsu et al.|Nature Biotechnology|2019Cited by 724
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Irene Scarfò et al.|Science Translational Medicine|2021Cited by 257